IP Library Granted Patent US 12,180,318
Granted Patent B2
US 12,180,318 · App. 17/317,259 · Granted Dec 31, 2024

Imidazolium zwitterion polymerizable compounds and ophthalmic devices incorporating them

Inventors: Shivkumar Mahadevan (Jacksonville, FL); Dola Sinha (Jacksonville, FL); Yong Zhang (Jacksonville, FL)
Assignee: Johnson & Johnson Vision Care, Inc.
C08F283/12A61F2/16C07D233/64G02B1/043
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,180,318
App. No.
17/317,259
Granted
Dec 31, 2024
Kind
B2
Abstract

Provided are imidazolium zwitterion polymerizable compounds and their applications in ophthalmic devices and packaging solutions. The zwitterionic polymerizable compounds are of formula I: wherein R 1 , R 2 , R 3 , L 1 , L 2 , and P g are as described herein.

Claims (29)

1. A zwitterionic polymerizable compound of formula I:

wherein R 1 , R 2 , and R 3 are independently H, alkyl, cycloalkyl, phenyl or benzyl;

L 1 and L 2 are each independently alkylene; and

P g is a polymerizable group.

2. The compound of claim 1 wherein R 1 is H or C 1 -C 6 alkyl.

3. The compound of claim 1 wherein R 2 is H.

4. The compound of claim 1 wherein R 3 is H.

5. The compound of claim 1 wherein P g comprises styryl, vinyl carbonate, vinyl ether, vinyl carbamate, N-vinyl lactam, N-vinylamide, (meth)acrylate, or (meth)acrylamide.

6. The compound of claim 1 that is:

3-(1-(3-methacrylamidopropyl)-1H-imidazol-3-ium-3-yl)propanoate;

3-(1-(3-methacrylamidopropyl)-2-methyl-1H-imidazol-3-ium-3-yl)propanoate; or

4-(1-(3-methacrylamidopropyl)-2-methyl-1H-imidazol-3-ium-3-yl)butanoate.

7. An ophthalmic device comprising a polymer derived from a zwitterionic polymerizable compound of formula I:

wherein R 1 , R 2 , and R 3 are independently H, alkyl, cycloalkyl, phenyl or benzyl; L 1 and L 2 are each independently a linking group; and P g is a polymerizable group.

8. The ophthalmic device of claim 7 wherein the polymer is contained in or is coated on the device.

9. The ophthalmic device of claim 7 wherein the polymer comprises a free radical reaction product of the compound and one or more monomers suitable for making the ophthalmic device.

10. The ophthalmic device of claim 9 wherein the monomer suitable for making the ophthalmic device is selected from a hydrophilic component, a hydrophobic component, a silicone-containing component, and mixtures of two or more thereof.

11. The ophthalmic device of claim 7 that is an intraocular lens or a soft contact lens.

12. The ophthalmic device of claim 11 that is a hydrogel contact lens.

13. A blister package including an ophthalmic device and a packaging solution, wherein the packaging solution comprises a polymer derived from a polymerizable zwitterion compound of formula I:

wherein R 1 , R 2 , and R 3 are independently H, alkyl, cycloalkyl, phenyl or benzyl; L 1 and L 2 are each independently a linking group; and P g is a polymerizable group.

14. The ophthalmic device of claim 7 wherein R 1 is H or C 1 -C 6 alkyl.

15. The ophthalmic device of claim 7 wherein R 2 is H and R 3 is H.

16. The ophthalmic device of claim 7 wherein L 1 and L 2 are independently alkylene.

17. The ophthalmic device of claim 7 wherein P g comprises styryl, vinyl carbonate, vinyl ether, vinyl carbamate, N-vinyl lactam, N-vinylamide, (meth)acrylate, or (meth)acrylamide.

18. The ophthalmic device of claim 7 wherein the zwitterionic polymerizable compound is:

3-(1-(3-methacrylamidopropyl)-1H-imidazol-3-ium-3-yl)propanoate;

3-(1-(3-methacrylamidopropyl)-2-methyl-1H-imidazol-3-ium-3-yl)propanoate; or

4-(1-(3-methacrylamidopropyl)-2-methyl-1H-imidazol-3-ium-3-yl)butanoate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2021
From: MAHADEVAN, SHIVKUMAR; SINHA, DOLA; ZHANG, YONG
To: JOHNSON & JOHNSON VISION CARE, INC.
Reel/Frame 056215/0144 →
Continuity (2)
Provisional Application 63039485 · Jun 16, 2020
Related Publication 20210388141A1 · Dec 16, 2021